Xeris Pharmaceuticals, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Xeris Pharmaceuticals, now known as Xeris Biopharma Holdings, Inc.
Industry & Market
Funding Information
Headcount Distribution
By Department
Department Breakdown
Keywords & Focus Areas
Overview
Founded in 2005 by Steve Prestrelski and John Kinzell, Xeris Pharmaceuticals, now Xeris Biopharma Holdings, Inc., is a biopharmaceutical organization headquartered in Chicago, Illinois. The company is dedicated to advancing patient care by developing and commercializing innovative therapeutic products, specializing in ready-to-use injectable formulations that aim to enhance convenience and treatment effectiveness.
Xeris's portfolio includes FDA-approved injectable therapies such as Gvoke, as well as treatments for rare diseases including primary periodic paralysis and Cushing's syndrome. Its proprietary formulation technology and 40 patent holdings position it as a leader in sustained-release medication. Strategic collaborations and acquisitions, like the 2020 integration of Strongbridge Biopharma, have further expanded the scope of its rare disease offerings, and the company continues to invest in innovative drug delivery platforms and pipeline development.
Key Metrics
Get Complete Company Metrics
Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.
Contact
Technology Stack
Analytics & Tracking
Social & Marketing
Database & Backend
Cloud & Infrastructure
Productivity
Compare similar companies to Xeris Pharmaceuticals, Inc.
Compare insights from companies similar to Xeris Pharmaceuticals, Inc., focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
| Company Name | Revenue | No. of Employees | Type | Funding | Founded In | Top Executive |
|---|---|---|---|---|---|---|
| xxxxxxx | $87893 | 85 | Private | - | 7837 | xxxxxxx |
| x | $11481 | 37 | Private | - | 2651 | xx |
| xxxxxxxxx | $59225 | 87 | Private | - | 7545 | xxxxxx |
| xxx | $3220 | 137 | Private | - | 7310 | xxxxx |
| xxxxxxxx | $65813 | 40 | Private | - | 7984 | xxxxxxxxxx |
Discover Similar Companies Instantly
Explore detailed insights and analysis on companies related to your search.